Table of Contents
ISRN Epidemiology
Volume 2013 (2013), Article ID 847283, 8 pages
http://dx.doi.org/10.5402/2013/847283
Research Article

Incidence and Prognostic Factors for Legionnaires' Disease in Denmark 1993–2006

1Department of Epidemiology, Statens Serum Institut, Ørestads Boulevard 5, 2300 Copenhagen S, Denmark
2Department of Microbiological Surveillance and Research, Statens Serum Institut, Ørestads Boulevard 5, 2300 Copenhagen S, Denmark

Received 4 May 2012; Accepted 10 June 2012

Academic Editors: A. Jin-xia Zhang and L. Lillienberg

Copyright © 2013 G. St-Martin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. M. W. Diederen, “Legionella spp. and Legionnaires' disease,” Journal of Infection, vol. 56, no. 1, pp. 1–12, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Carratala and C. Garcia-Vidal, “An update on Legionella,” Current Opinion in Infectious Diseases, vol. 23, no. 2, pp. 152–157, 2010. View at Publisher · View at Google Scholar
  3. H. von Baum, S. Ewig, R. Marre et al., “Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia,” Clinical Infectious Diseases, vol. 46, no. 9, pp. 1356–1364, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. R. B. Brown, “Legionella pneumonia: the spectrum continues to expand,” Chest, vol. 125, no. 6, pp. 1979–1980, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. C. W. Olsen, P. Elverdal, C. S. Jørgensen, and S. A. Uldum, “Comparison of the sensitivity of the Legionella urinary antigen EIA kits from Binax and Biotest with urine from patients with infections caused by less common serogroups and subgroups of Legionella,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 28, no. 7, pp. 817–820, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. El-Ebiary, X. Sarmiento, A. Torres et al., “Prognostic factors of severe Legionella pneumonia requiring admission to ICU,” American Journal of Respiratory and Critical Care Medicine, vol. 156, no. 5, pp. 1467–1472, 1997. View at Google Scholar · View at Scopus
  7. A. Gacouin, Y. Le Tulzo, S. Lavoue et al., “Severe pneumonia due to Legionella pneumophila: prognostic factors, impact of delayed appropriate antimicrobial therapy,” Intensive Care Medicine, vol. 28, no. 6, pp. 686–691, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. L. S. Tkatch, S. Kusne, W. D. Irish, S. Krystofiak, and E. Wing, “Epidemiology of Legionella pneumonia and factors associated with Legionella-related mortality at a tertiary care center,” Clinical Infectious Diseases, vol. 27, no. 6, pp. 1479–1486, 1998. View at Google Scholar · View at Scopus
  9. M. Poupard, C. Campèse, P. Bernillon, and D. Che, “Factors associated with mortality inLegionnaires' disease, France, 2002–2004,” Medecine et Maladies Infectieuses, vol. 37, no. 6, pp. 325–330, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Dominguez, J. Alvarez, M. Sabria et al., “Factors influencing the case-fatality rate of Legionnaires' disease,” International Journal of Tuberculosis and Lung Disease, vol. 13, no. 3, pp. 407–412, 2009. View at Google Scholar · View at Scopus
  11. B. J. Marston, H. B. Lipman, and R. F. Breiman, “Surveillance for legionnaires' disease: risk factors for morbidity and mortality,” Archives of Internal Medicine, vol. 154, no. 21, pp. 2417–2422, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Jespersen, O. S. Søgaard, H. C. Schønheyder, M. J. Fine, and L. Østergaard, “Clinical features and predictors of mortality in admitted patients with community- and hospital-acquired legionellosis: a Danish historical cohort study,” BMC Infectious Diseases, vol. 10, article 124, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. K. D. Lettinga, A. Verbon, G. J. Weverling et al., “Legionnaires' disease at a Dutch flower show: prognostic factors and impact of therapy,” Emerging Infectious Diseases, vol. 8, no. 12, pp. 1448–1454, 2002. View at Google Scholar · View at Scopus
  14. B. P. Howden, R. L. Stuart, G. Tallis, M. Bailey, and P. D. R. Johnson, “Treatment and outcome of 104 hospitalized patients with legionnaires' disease,” Internal Medicine Journal, vol. 33, no. 11, pp. 484–488, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. J. W. D. Boer, J. Nijhof, and I. Friesema, “Risk factors for sporadic community-acquired Legionnaires' disease. A 3-year national case-control study,” Public Health, vol. 120, no. 6, pp. 566–571, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. A. L. Benin, R. F. Benson, and R. E. Besser, “Trends in legionnaires disease, 1980–1998: declining mortality and new patterns of diagnosis,” Clinical Infectious Diseases, vol. 35, no. 9, pp. 1039–1046, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. J. H. Helbig, S. Bernander, M. Castellani Pastoris et al., “Pan-European study on culture-proven Legionnaires' disease: distribution of Legionella pneumophila serogroups and monoclonal subgroups,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 21, no. 10, pp. 710–716, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Ginevra, A. Duclos, P. Vanhems et al., “Host-related risk factors and clinical features of community-acquired legionnaires disease due to the Paris and Lorraine endemic strains, 1998–2007, France,” Clinical Infectious Diseases, vol. 49, no. 2, pp. 184–191, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. K. D. Ricketts and C. A. Joseph, “Legionnaires disease in Europe: 2005–2006,” Euro Surveillance, vol. 12, no. 12, article 4, 2007. View at Google Scholar · View at Scopus
  20. A. Mykietiuk, J. Carratalà, N. Fernández-Sabé et al., “Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy,” Clinical Infectious Diseases, vol. 40, no. 6, pp. 794–799, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Sopena, L. Force, M. L. Pedro-Botet et al., “Sporadic and epidemic community legionellosis: two faces of the same illness,” European Respiratory Journal, vol. 29, no. 1, pp. 138–142, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Alvarez, A. Domínguez, M. Sabrià et al., “Impact of the Legionella urinary antigen test on epidemiological trends in community outbreaks of legionellosis in Catalonia, Spain, 1990–2004,” International Journal of Infectious Diseases, vol. 13, no. 6, pp. e365–e370, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. O. Tello, C. Pelaz, A. Garcia-Fulgueiras, C. Joseph, J. Kool, J. Lee et al., “Update on the outbreak of legionnaires' disease in Murcia, Spain,” Eurosurveillance, vol. 5, no. 29, article 1714, 2001. View at Google Scholar